Description / Application
Dapagliflozin is a C-glycosyl comprising beta-D-glucose in which the anomeric hydroxy group is replaced by a 4-chloro-3-(4-ethoxybenzyl)phenyl group. Used (in the form of its propanediol monohydrate) to improve glycemic control, along with diet and exercise, in adults with type 2 diabetes. It has a role as a hypoglycemic agent and a sodium-glucose transport protein subtype 2 inhibitor. It is a C-glycosyl compound, an aromatic ether and a member of monochlorobenzenes.
Identities
| Alternative Name | BMS512148, (1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol |
|---|---|
| Molecular Formula | C21H25ClO6 |
| Molecular Weight | 408.9 |
| MFCD | MFCD13182359 |
Safety
| Pictograms |
|
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302;H315;H319;H335 |
| Precautionary Statements | P261;P264;P270;P271;P280;P301+P312;P305+P352;P304+P340;P305+P351+P338;P312;P330;P332+P313;P337+P313;P362;P403+P233;P405;P501 |